SNNNYSE · Orthopedic, Prosthetic & Surgical Appliances & Supplies

SMITH & NEPHEW PLC

Alert me on SNN

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Jul 21 Buy Sen. Alan Armstrong Senate

1 week

+9.1%S&P −2.4%

1 month

−3.0%S&P +2.0%

3 months

−0.9%S&P +3.2%

6 months

Result in60 trading days

Aug 13, 2025 Buy Rep. Lisa McClain House

1 week

+1.0%S&P −1.5%

1 month

+2.1%S&P +2.5%

3 months

−7.8%S&P +6.3%

6 months

−0.4%S&P +6.3%

Aug 13, 2025 Sale Rep. Lisa McClain House

1 week

+1.0%S&P −1.5%

1 month

+2.1%S&P +2.5%

3 months

−7.8%S&P +6.3%

6 months

−0.4%S&P +6.3%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for SNN

7 held · newest 57 held · newest 2

Loading the filings.

See all 7 filings for SNN

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Signal history

No signal for this ticker yet. A signal is written when insider buying here scores one dot or more.

Stakes

Jul 23, 2026 Schedule 13D, amended

Cevian Capital II GP Limited: 14.2%, 119,179,419 shares

Jun 22, 2026 Schedule 13D, amended

Cevian Capital II GP Limited: 13.1%, 110,804,501 shares

Jun 1, 2026 Schedule 13D, amended

Cevian Capital II GP LTD: 11.9%, 101,046,788 shares

Apr 30, 2026 Schedule 13D, amended

Cevian Capital II GP LTD: 10.7%, 91,462,095 shares

Mar 12, 2026 Schedule 13D, amended

Cevian Capital II GP LTD: 9.6%, 81,687,136 shares

Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

$340KQ4 2025

$420KQ1 2026

$490KQ2 2026

$480KQ3 2026

Down 2 percent from Q2 2026. Reported by the company to the Senate each quarter.Original report ↗

Read from LDA.gov between Sep 23, 2026 and Oct 21, 2026. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.